Fertilet 2.5 mg Tablets contain Letrozole, a non-steroidal aromatase inhibitor primarily used for ovulation induction in women with infertility and also for the treatment of hormone-responsive breast cancer in postmenopausal women. It works by lowering estrogen levels, which stimulates ovulation and inhibits estrogen-dependent tumor growth.
Uses / Indications
Fertilet 2.5 mg is indicated for:
-
Ovulation induction in women with infertility
-
Polycystic Ovary Syndrome (PCOS)–related infertility
-
Unexplained infertility (as prescribed by a gynecologist)
-
Hormone receptor-positive breast cancer (postmenopausal women)
Mechanism of Action
Letrozole inhibits the aromatase enzyme responsible for converting androgens into estrogen.
This results in:
-
Reduced estrogen levels
-
Increased release of follicle-stimulating hormone (FSH)
-
Stimulation of ovarian follicle development
-
Suppression of estrogen-dependent cancer cell growth
Dosage & Administration
-
Infertility treatment:
Usually 2.5 mg once daily for 5 days (commonly from Day 3–7 of menstrual cycle) -
Breast cancer:
As prescribed by the oncologist
⚠️ Dosage and duration must be strictly followed as advised by the doctor.
Side Effects
Common side effects:
-
Headache
-
Hot flashes
-
Fatigue
-
Dizziness
-
Nausea
Less common:
-
Joint or muscle pain
-
Mood changes
-
Increased sweating
Rare but serious:
-
Bone density loss with long-term use
Precautions & Warnings
-
Not recommended during pregnancy
-
Avoid use during breastfeeding
-
Use with caution in liver disorders
-
Monitor ovulation under medical supervision
-
Prescription-only medicine
Drug Interactions
-
Estrogen-containing medicines may reduce effectiveness
-
Inform doctor about hormonal therapies or supplements
Storage Instructions
-
Store below 25°C
-
Protect from light and moisture
-
Keep out of reach of children
Key Highlights
-
Widely prescribed for ovulation induction
-
Effective in PCOS-related infertility
-
Short treatment duration
-
Trusted formulation by Cipla
-
Also used in hormone-dependent breast cancer management

Reviews
There are no reviews yet.